Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
103,558,110
-
Share change
-
-2,386,607
-
Total reported value
-
$6,396,398,533
-
Put/Call ratio
-
139%
-
Price per share
-
$61.74
-
Number of holders
-
283
-
Value change
-
-$140,860,036
-
Number of buys
-
143
-
Number of sells
-
111
Institutional Holders of ISIS PHARMACEUTICALS INC - COM (ISIS) as of Q4 2014
As of 31 Dec 2014,
ISIS PHARMACEUTICALS INC - COM (ISIS) was held by
283 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,558,110 shares.
The largest 10 holders included
FMR LLC, Clearbridge Investments, LLC, VANGUARD GROUP INC, BB Biotech AG, WADDELL & REED FINANCIAL INC, BlackRock Fund Advisors, Artisan Partners Limited Partnership, BlackRock Institutional Trust Company, N.A., PRICE T ROWE ASSOCIATES INC /MD/, and State Street Corp.
This page lists
283
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.